**Question:** The most common second malignant in survivors of retinoblastoma is –

A. Soft tissue sarcoma
B. Osteosarcoma
C. Lymphoma
D. Leukemia

**Core Concept:** Retinoblastoma is a rare childhood cancer of the eye, primarily affecting children under the age of five. It occurs due to the uncontrolled growth of retinal cells caused by mutations in the RB1 gene, which is responsible for regulating cell cycle progression.

**Why the Correct Answer is Right:**

D. Leukemia is the most common second malignant neoplasm in retinoblastoma survivors. This increased risk is attributed to the constitutive activation of the RB1 tumor suppressor pathway, which leads to genomic instability and a higher susceptibility to develop leukemia. The treatment of retinoblastoma, involving radiation therapy and chemotherapy, further increases the risk of developing leukemia due to the damaging effects on hematopoietic stem cells.

**Why Each Wrong Option is Incorrect:**

A. Soft tissue sarcoma is an unrelated malignancy that does not directly result from the RB1 gene mutation or treatment-related complications.
B. Osteosarcoma is a bone cancer, while retinoblastoma is an eye cancer. Additionally, osteosarcoma is less common among retinoblastoma survivors compared to leukemia.
C. Lymphoma is a malignancy of lymphoid cells and is less common than leukemia in retinoblastoma survivors.

**Clinical Pearl:** Survivors of retinoblastoma require long-term surveillance for second malignant neoplasms, particularly leukemia. Early detection is crucial to improve outcomes and reduce mortality.

**Correct Answer:** D. Leukemia